psoriasis
FDA Approves Wezlana, an Interchangeable Biosimilar for Stelara
An interchangeable designation means the biosimilar may be substituted for the reference product without consulting ...
NOVEMBER 1, 2023
FDA Expands Indication for Abatacept to Treat Juvenile Psoriatic Arthritis
The FDA expanded the indication for abatacept for the treatment of patients 24 months of age and older with active ...
NOVEMBER 1, 2023
Phase 2b Trial: TAK-279 Improves Skin Clearance for Moderate to Severe Plaque Psoriasis
Results from a phase 2b trial indicate that the investigational drug TAK-279 (Takeda) significantly improved ...
MARCH 20, 2023
FDA Approves Sotyktu for Patients With Moderate to Severe Plaque Psoriasis
Deucravacitinib is indicated for adults with moderate to severe plaque psoriasis who are candidates for systemic ...
SEPTEMBER 13, 2022
FDA Approves Spevigo, First Treatment for Generalized Pustular Psoriasis Flares
More than half of patients treated with spesolimab-sbzo showed no visible pustules one week after receiving ...
SEPTEMBER 9, 2022
FDA Grants Second Indication for Skyrizi
Risankizumab-rzaa is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 ...
JANUARY 24, 2022
Cosentyx Improves Symptoms, QOL for Children With Psoriasis
Plaque psoriasis is the most common type of psoriasis in children.
MAY 7, 2021
As IL-17s Replace Other Biologics for Psoriasis, Patients Report Improvements, Greater Adherence
Nearly half of patients with psoriasis who switched to an IL-17 inhibitor from a non-IL-17 biologic reported ...
SEPTEMBER 18, 2019
Psoriasis Therapy Linked to Reduced Coronary Inflammation
A second study finds that anti-inflammatory biologic therapies used to treat moderate to severe psoriasis can ...
AUGUST 13, 2019
Study Links Psoriasis Therapy to Improved Heart Disease
Treating psoriasis with biologic drugs that target inflammation can reduce the early plaque buildup that leads to ...
FEBRUARY 14, 2019
Secukinumab Rx Improves Quality-of-Life Measurements as Early as 4 Weeks
Findings suggest that helping patients feel better through improved quality of life and ability to function ...
JANUARY 28, 2019
Psoriasis Severity Linked to Increased Risk for Death
The risk of death almost doubles for psoriasis patients, which have plaques on 10% or more of their body surface, ...
AUGUST 29, 2017
